PHARMA
A*STAR & Chugai’s Anti-Dengue Antibody Project Receives GHIT Funding
The Global Health Innovative Technology Fund has awarded a US$5.3 million grant to help develop an antibody that can neutralize all four dengue serotypes.
INCJ, Takeda And Medipal Holdings Launch Scohia Pharma
The joint venture biotechnology spinoff has taken over eight renal, metabolic and cardiovascular projects from Takeda.
Tessa Therapeutics Completes Acquisition of Euchloe Bio
Tessa Therapeutics has fully acquired Euchloe Bio, a biotech company focused on developing and commercializing therapeutic antibodies.
BeiGene Receives US$320 Million To Build Biologics Facility In China
BeiGene Co. Ltd. and Guangzhou Development District have entered into a joint venture worth US$330 million to build a state-of-the-art biologics manufacturing plant.
CMBG Receives US$2.29 Million Grant For Stem Cell Therapy
China's Cellular Biomedicine Group has received US$2.29 million to support pre-clinical studies of stem cell therapy for knee osteoarthritis.
Astellas And Affinivax Team Up For Vaccine Against Pneumococcal Disease
The collaboration centers on Affinivax's multiple antigen presenting system to develop a vaccine targeted against pneumococcal disease.
PerkinElmer Launches Vectra® Polaris™ Automated Quantitative Pathology Imaging System
The new platform helps research immuno-oncologists and pathologists accelerate the study of cancer.
Cipla Launches Hepatitis B Vaccine In India
Cipla's hepatitis B vaccine can prevent 95 percent of the recipients from developing a chronic infection, protecting them for decades.
Takeda Donates US$1 Million For Cancer Research
Japanese pharmaceutical Takeda has donated US$1 million to the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology.
